CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Head & Neck Cancer

ONCOLOGY. Vol. 9 No. 6
Pages: 1  2  3  
Previous
REVIEW ARTICLE 

Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer

By Scott P. Stringer, MD1 | May 31, 1995
1 Department of Otolaryngology, University of Florida College of Medicine, Gainesville, Florida

Indications for Postoperative Irradiation

The decision to use postoperative irradiation in head and neck cancer is based on the initial tumor stage and pathologic findings. Both the primary site and neck must be considered in this regard.

Specific to the neck, postoperative irradiation is indicated for extranodal tumor spread or multiple positive nodes, especially at multiple levels. In addition, irradiation is useful for controlling the opposite, undissected neck when it is at risk and the primary site will need postoperative irradiation.

Management of Neck Metastases From an Unknown Primary

(MORE: Commentary (Goodwin): Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer)

Cervical metastases arise overwhelmingly from upper aerodigestive tract squamous cell carcinoma primary sites, although metastases that appear first in the lower portion of the neck may be of infraclavicular origin. When upper- or middle-third cervical metastases are present without an obvious primary site, we recommend a thorough search for that site, including imaging and endoscopy of the upper aerodigestive tract. If no primary is found, histopathology of the lymph node is almost always obtainable by means of fine-needle aspiration cytology.

It is rarely necessary to perform a cervical node excision for diagnostic purposes. If a node excision is required, or is inadvisably performed, radiation must be the next modality utilized in order to achieve a reasonable rate of regional control [21]. This approach may, however, unduly complicate the management of the patient.

Results of Treatment

Survival rates in head and neck cancer vary widely, due to the large number of primary sites and different primary tumor sizes. However, various factors have been examined relative to their influence on the control of regional metastases by neck dissection. Extranodal spread of tumor, which increases in proportion to lymph node size, has been identified as a very important factor affecting regional control and survival [22-24]. An increased risk of distant metastases and a decrease in survival have been demonstrated with an increasing number of positive lymph nodes, particularly when located in the lower neck [22,25,26].

Regional control rates may also be examined with regard to treatment selection. Regional control rates for negative necks or necks with a single, positive node less than 3 cm managed with any type of neck dissection should be 90% or greater [12]. Several retrospective studies have demonstrated no difference in nodal recurrence rates between modified and radical neck dissections for appropriately selected patients [15,27,28].

Similar control rates (90% or greater) may be obtained with irradiation for N0 or early N1 neck disease [29]. For more advanced nodal disease, control rates are improved with a combination of neck dissection and radiation, as compared with either modality alone [12,30].

The salvage rate for recurrence in a previously dissected or previously irradiated neck is low, ranging from 5% to 40%, and salvage appears to be more likely if irradiation has not been previously employed [30,31].

Surgical Considerations

Prevention of Carotid Artery Rupture

Major vascular complications of neck dissection, especially carotid artery rupture, are often catastrophic. In an isolated neck dissection, carotid rupture is an extremely rare event. Carotid artery exposure occurs almost exclusively after the development of a pharyngocutaneous or orocutaneous fistula. Carotid exposure appears to be much less common after modified radical neck dissection, due to the protection provided by the sternocleidomastoid muscle.

Proper skin flap thickness and the placement of skin incisions away from the carotid bifurcation are helpful in preventing carotid exposure. In addition, the adventitia should be left on the carotid, unless there is a positive node partially fixed to the artery.

Once the outer layer of the carotid is exposed, it desiccates and weakens, most commonly at the level of the carotid bifurcation. Full-thickness destruction occurs within approximately 1 to 2 weeks. The first sign of an impending carotid rupture may be a sentinel bleed, which is then usually followed by an actual rupture 24 to 48 hours later. If rupture occurs, the common, internal, and external carotid arteries are ligated, and the bifurcation is resected.

Ligation and resection of the carotid artery for rupture have been associated with death rates of 33% to 50% and neurologic sequelae rates of 15% to 25% among survivors [32]. Elective resection for impending rupture is associated with decreased morbidity and mortality when compared with emergent resection. In highly selected cases, balloon occlusion of the carotid may be useful as a temporizing measure and for the prediction of neurologic outcome. However, despite the results of such a test, the artery most often will still require ligation.

Various methods of tissue coverage have been suggested for the prevention of carotid exposure after radical neck dissection; however, the effectiveness of such attempts is not clear [32]. Although dermal grafts are employed most commonly, the use of levator scapulae muscle flaps, omentum, and prevertebral fascia has been described. Dermal grafting is most likely to be of benefit in cases of radical neck dissection that have a possibility of a pharyngocutaneous or orocutaneous fistula and a history of prior irradiation, especially if the carotid adventitia was removed.

Sacrifice of the Internal Carotid Artery

If irradiation has not been successful in freeing a fixed node from the carotid artery, a decision must be made relative to carotid artery resection. Even though carotid artery resection with bypass may result in acceptable perioperative morbidity and mortality [33], we generally do not perform this maneuver, as survival is not improved with carotid artery resection [34,35].

Reference Guide
Therapeutic Agents
Mentioned in This Article
Bleomycin(Drug information on bleomycin)
Carboplatin(Drug information on carboplatin)
Carmustine
Cisplatin(Drug information on cisplatin)
Cetuximab(Drug information on cetuximab) (Erbitux)
Docetaxel (Taxotere)
Erlotinib (Tarceva)
Fluorouracil(Drug information on fluorouracil)
Gefitinib(Drug information on gefitinib) (Iressa)
Hydroxyurea
Lomustine(Drug information on lomustine)
Methotrexate(Drug information on methotrexate)
Mitomycin(Drug information on mitomycin)
Paclitaxel
Procarbazine(Drug information on procarbazine)

Brand names are listed in parentheses only if a drug is not available generically and is marketed as no more than two trademarked or registered products. More familiar alternative generic designations may also be included parenthetically.

Benefit of Saving the Spinal Accessory Nerve

A variety of neural injuries may be evident after neck dissection, but injuries to the spinal accessory nerve predominate. The spinal accessory nerve passes through the lymph node-bearing tissue of the neck, requiring that it either be sacrificed or dissected for preservation.

The majority of permanent spinal accessory nerve injuries are associated with the purposeful sacrifice of the nerve in conjunction with a radical neck dissection. This results in denervation of the trapezius muscle. The associated "shoulder syndrome" consists of shoulder pain, weakness, impaired mobility in abduction of the arm over 90°, shoulder droop, and scapular winging. The shoulder pain is due to the increased demands for support of the scapula on the levator scapulae and rhomboid muscles, and is worse if the dorsal scapular nerve is also injured. An adhesive capsulitis of the shoulder joint may develop as well, and predominate symptomatically [36].

Because loss of the spinal accessory nerve is generally the most debilitating part of a radical neck dissection, various methods of preserving trapezius function have been utilized. Given that the spinal accessory nerve receives contributions from the second, third, and fourth cervical nerves, preservation of these branches was proposed as a method of preserving some trapezius function. However, it now seems clear that these branches are mostly proprioceptive in nature, and any residual shoulder function was more likely due to preservation of the nerve to the levator scapulae muscle.

Resection of the spinal accessory nerve and cable grafting achieves some diminution of the shoulder syndrome. A "save XI" neck dissection still results in significant atrophy of the trapezius in up to 50% of patients, due to the extensive trauma to the nerve and devascularization associated with this procedure.

Modified radical neck dissection with preservation of the sternocleidomastoid muscle and spinal accessory nerve is associated with the least trauma to and devascularization of the spinal accessory nerve. This ultimately results in the best trapezius function, although there is still a temporary phase of dysfunction, which recovers significantly by 6 months after neck dissection, as documented by electrodiagnostic testing [37]. Since modified radical neck dissection is associated with acceptable nodal recurrence rates, this has become the nerve-sparing procedure of choice.

Benefit of Saving the Internal Jugular Vein

The internal jugular vein is typically conserved in modified radical and selective neck dissections. This allows the performance of simultaneous bilateral neck dissections with a diminished risk of increased intracranial pressure, the syndrome of inappropriate antidiuretic hormone secretion, facial edema, blindness, stroke, and airway obstruction.

The benefit of saving the internal jugular vein during a unilateral neck dissection is not as clear, but logically would seem to be of benefit, to a lesser degree. The internal jugular vein has been demonstrated to be reliably patent following conservation procedures. Factors that are associated with the rare instance of internal jugular vein thrombosis include prior irradiation, nodal recurrence, and compression by a musculocutaneous flap [38-40].

Conclusion

The surgical management of cervical metastases from head and neck cancer has undergone a significant change to more conservative techniques for appropriately selected individuals. Improved imaging modalities facilitate the staging of cervical metastases. The selection of the appropriate treatment for the neck is best done by a multidisciplinary group of surgeons, radiation oncologists, medical oncologists, path- ologists, and radiologists due to the complex relationship between the management of the primary site and the neck.

Pages: 1  2  3  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This article reviewed

Commentary (Schuller): Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer

Commentary (Goodwin): Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer



David E. Schuller, MD
W. Jarrad Goodwin, MD, FACS


1. Crile G: Excision of cancer of the head and neck with special reference to the plan of dissection based upon one hundred thirty-two operations. JAMA 47:1780-1786, 1906.

2. Martin HE, De Valle B, Ehrlich H, et al: Neck dissection. Cancer 4:441-449, 1951.

3. Lindberg RD: Distribution of cervical lymph node metastases from squamous cell carcinoma of upper respiratory and digestive tracts. Cancer 29:1446-1449, 1972.

4. Mendenhall WM, Million RR: Elective neck irradiation for squamous cell carcinoma of the head and neck: Analysis of time-dose factors and causes of failure. Int J Radiat Oncol Biol Phys 12:741-746, 1986.

5. Stevens MH, Harnsberger HR, Mancuso AA, et al: Computed tomography of cervical lymph nodes. Arch Otolaryngol Head Neck Surg 111:735-739, 1985.

6. van den Brekel MW, Castelijns JA, Croll GA, et al: Magnetic resonance imaging vs palpation of cervical lymph node metastasis. Arch Otolaryngol Head Neck Surg 117:663-673, 1991.

7. Hughes CJ, Gallo O, Spiro RH, et al: Management of occult neck metastases in oral cavity squamous ca. Am J Surg 166:380-383, 1993.

8. Jesse RH, Barkley HT, Lindberg RD, et al: Cancer of the oral cavity: Is elective neck dissection beneficial? Am J Surg 120:505-508, 1970.

9. Mendenhall WM, Million RR, Cassisi NJ: Elective neck irradiation in squamous cell ca of the head and neck. Head Neck 3:15-20, 1980.

10. Friedman M, Mafee MF, Pacella BL: Rationale for elective neck dissection in 1990. Laryngoscope 100:54-59, 1990.

11. Weiss MH, Harrison LB, Isaacs RS: Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 120:699-702, 1994.

12. Byers RM: Modified neck dissection: A study of 967 cases from 1970 to 1980. Am J Surg 150:414-421, 1985.

13. Medina JE: A rational classification of neck dissections. Otolaryngol Head Neck Surg 100:169-176, 1989.

14. Molinari R, Chiesa F, Cantu G, et al: Retrospective comparison of conservative and radical neck dissection in laryngeal cancer. Ann Otol 89:578-581, 1980.

15. Lingeman RE, Stephens R, Helmus C, et al: Neck dissection: Radical or conservative. Ann Otol 86:737-744, 1977.

16. Gavilan C, Gavilan J: Five-year results of functional neck dissection for cancer of the larynx. Arch Otolaryngol Head Neck Surg 115:1193-1196, 1989.

17. Bocca E, Pignataro O: A conservation technique in radical neck dissection. Ann Otol Rhinol Laryngol 76:975-987, 1967.

18. Wenig BL, Applebaum EL: The submandibular triangle in squamous cell ca of the larynx and hypopharynx. Laryngoscope 101:516, 1991.

19. Ballantyne AJ: Significance of retropharyngeal nodes in cancer of the head and neck. Am J Surg 108:500-504, 1964.

20. Hasegawa Y, Matsuura H: Retropharyngeal node dissection in cancer of the oropharynx and hypopharynx. Head Neck 16:173-180, 1994.

21. Parsons JT, Million RR, Cassisi NJ: The influence of excisional or incisional biopsy of metastatic neck nodes on the management of head and neck cancer. Int J Radiat Oncol Biol Phys 11:1447-1454, 1985.

22. Snow GB, Annyas AA, van Slooten EA, et al: Prognostic factors of neck node metastasis. Clin Otolaryngol 7:185-192, 1982.

23. Johnson JT, Barnes EL, Myers EN, et al: The extracapsular spread of tumor in cervical node metastasis. Arch Otolaryngol Head Neck Surg 107:725-729, 1981.

24. Hirabayashi H, Koshii K, Uno K, et al: Extracapsular spread of squamous cell carcinoma in neck lymph nodes: Prognostic factor of laryngeal cancer. Laryngoscope 101:502-506, 1991.

25. Ellis ER, Mendenhall WM, Rao PV, et al: Does node location affect the incidence of distant metastases in head and neck squamous cell ca? Int J Radiat Oncol Biol Phys 17:293-297, 1989.

26. Strong EW: Preoperative radiation and neck dissection. Surg Clin North Am 49:271-276, 1969.

27. Skolnik EM, Deutsch EC: Conservative neck dissection. Laryngoscope 95:561-565, 1985.

28. Jesse RM, Ballantyne AJ, Larson D: Radical or modified neck dissection: A therapeutic dilemma. Am J Surg 136:516-519, 1978.

29. Barkley HT, Fletcher GH, Jesse RH, et al: Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg 124:462-467, 1972.

30. Mendenhall WM, Million RR, Cassisi NJ: Squamous cell carcinoma of the head and neck treated with radiation therapy: The role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 12:733-740, 1986.

31. Grandi C, Mingardo M, Guzzo M, et al: Salvage surgery of cervical recurrences after neck dissection or radiotherapy. Head Neck 15:292-295, 1993.

32. Hillerman BL, Kennedy TL: Carotid rupture and tissue coverage. Laryngoscope 92:985-988, 1982.

33. Biller HF, Urken M, Lawson W, et al: Carotid artery resection and bypass for neck carcinoma. Laryngoscope 98:181-183, 1988.

34. Brennan JA, Jafek BW: Elective carotid artery resection for advanced squamous cell ca of the neck. Laryngoscope 104:259-263, 1994.

35. Meleca RJ, Marks SC: Carotid artery resection for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 120:974-978, 1994.

36. Patten C, Hillel AD: The 11th nerve syndrome: Accessory nerve palsy or adhesive capsulitis? Arch Otolaryngol Head Neck Surg 119:215-220, 1993.

37. Remmler D, Byers R, Scheetz J, et al: A prospective study of shoulder disability resulting from radical and modified neck dissections. Head Neck 8:280-286, 1986.

38. Cotter CS, Stringer SP, Landau S, et al: Patency of the internal jugular vein following modified radical neck dissection. Laryngoscope 104:841-845, 1994.

39. Lake GM, Dinardo LJ, Demeo JH: Performance of the internal jugular vein after functional neck dissection. Otolaryngol Head Neck Surg 111:201-204, 1994.

40. Docherty JG, Carter R, Sheldon CD, et al: Relative effect of surgery and radiotherapy on the internal jugular vein following functional neck dissection. Head Neck 15:553-556, 1993.


 
RELATED CONTENT

Parotid Gland Swelling in 45-Year-Old Patient
May 6, 2013
Status of HPV-Related Cancers and Vaccination Trends
February 21, 2013
A 53-Year-Old Man Presents With Painful Neck Swelling
August 30, 2012
Laryngeal Mass Discovered in 46-Year-Old Man
July 23, 2012
Locoregional Recurrence of an HPV-Positive Squamous Cell Carcinoma of the Head and Neck
ONCOLOGY,  October 12, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • A 49-Year-Old Woman Develops Thickened and Bound-Down Skin
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Head And Neck Cancer
Evidence on Head And Neck Cancer
Guidelines on Head And Neck Cancer
Patient Education on Head And Neck Cancer
Clinical Trials on Head And Neck Cancer
Practical Articles on Head And Neck Cancer
Research and Reviews on Head And Neck Cancer
All "Head And Neck Cancer" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy